7921 related articles for article (PubMed ID: 10761786)
1. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
Balch CM; Soong SJ; Bartolucci AA; Urist MM; Karakousis CP; Smith TJ; Temple WJ; Ross MI; Jewell WR; Mihm MC; Barnhill RL; Wanebo HJ
Ann Surg; 1996 Sep; 224(3):255-63; discussion 263-6. PubMed ID: 8813254
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
Balch CM; Soong SJ; Smith T; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Desmond R;
Ann Surg Oncol; 2001 Mar; 8(2):101-8. PubMed ID: 11258773
[TBL] [Abstract][Full Text] [Related]
4. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
6. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
7. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
[TBL] [Abstract][Full Text] [Related]
9. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma of the head and neck: effect of treatment on survival.
Peralta EA; Yarington CT; Glenn MG
Laryngoscope; 1998 Feb; 108(2):220-3. PubMed ID: 9473071
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic advantage for defined risk groups by lymphocyte dissection. Long-term study of 3,616 melanoma patients].
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Kölmel K
Hautarzt; 1994 Sep; 45(9):615-22. PubMed ID: 7960769
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
McCarthy WH; Shaw HM; Milton GW
Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous thick melanoma. Prognosis and treatment.
Schneebaum S; Briele HA; Walker MJ; Greager J; Wood DK; Ronan SG; Patel MK; Das Gupta TK
Arch Surg; 1987 Jun; 122(6):707-11. PubMed ID: 3579586
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
17. [Elective lymph node dissection in primary malignant melanoma].
Petres J; Rompel R; Büttner P; Teichelmann K; Garbe C
Hautarzt; 1996 Jan; 47(1):29-34. PubMed ID: 8835001
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
19. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
20. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991.
Coates AS; Ingvar CI; Petersen-Schaefer K; Shaw HM; Milton GW; O'Brien CJ; Thompson JF; McCarthy WH
J Am Coll Surg; 1995 Apr; 180(4):402-9. PubMed ID: 7719543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
